60 degrees pharmaceuticals announces pricing of initial public offering

Washington, july 12, 2023 (globe newswire) -- 60 degrees pharmaceuticals, inc., (nasdaq: sxtp; sxtpw) ("60p" or the "company"), specialists in developing and marketing medicines for infectious diseases, announced today the pricing of its initial public offering of 1,415,095 units (each, a "unit," collectively, the "units") at a price of $5.30 per unit for a total of approximately $7.5 million of gross proceeds to the company. each unit is comprised of one share of the company's common stock, one tradeable warrant (each, a "tradeable warrant," collectively, the "tradeable warrants") to purchase one share of common stock at an exercise price of $6.095 per share, and one non-tradeable warrant (each, a "non-tradeable warrant," collectively, the "non-tradeable warrants"; together with the tradeable warrants, each, a "warrant," collectively, the "warrants") to purchase one share of the company's common stock at an exercise price of $6.36.
SXTP Ratings Summary
SXTP Quant Ranking